104 related articles for article (PubMed ID: 7850755)
1. Elevated frequency of a SstI polymorphism of the Ets-1 oncogene in non-Hodgkin's lymphoma patients.
Crossen PE; Morrison MJ; Colls BM
Cancer Genet Cytogenet; 1995 Jan; 79(1):70-3. PubMed ID: 7850755
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
Crossen PE; Morrison MJ; Colls BM
Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
[TBL] [Abstract][Full Text] [Related]
3. Elevated frequency of an ETS-1 restriction fragment polymorphism in chronic B-cell leukaemia.
Crossen PE; Morrison MJ
Hum Genet; 1993 May; 91(4):380-2. PubMed ID: 8099060
[TBL] [Abstract][Full Text] [Related]
4. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
Chenevix-Trench G; Southall M; Kidson C
Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
[TBL] [Abstract][Full Text] [Related]
5. Allelic variation of the c-raf-1 oncogene in non-Hodgkin's lymphoma.
Chenevix-Trench G; Behm F; Westin E
Leukemia; 1987 Jan; 1(1):82-6. PubMed ID: 2889852
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
7. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma.
Purdue MP; Lan Q; Kricker A; Vajdic CM; Rothman N; Armstrong BK
Haematologica; 2007 Aug; 92(8):1145-6. PubMed ID: 17650449
[TBL] [Abstract][Full Text] [Related]
9. Novel restriction fragment length polymorphisms in the cellular oncogene SEA.
Koduru PR; Goh JC; Broome JD
Hematol Pathol; 1992; 6(2):71-8. PubMed ID: 1351480
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Sarmanová J; Benesová K; Gut I; Nedelcheva-Kristensen V; Tynková L; Soucek P
Hum Mol Genet; 2001 Jun; 10(12):1265-73. PubMed ID: 11406608
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
12. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
14. The molecular genetics of human non-Hodgkin's lymphoma.
Chenevix-Trench G
Cancer Genet Cytogenet; 1987 Aug; 27(2):191-213. PubMed ID: 3297303
[TBL] [Abstract][Full Text] [Related]
15. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
Trench GC; Southall M; Smith P; Kidson C
Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
[TBL] [Abstract][Full Text] [Related]
16. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 14: a breakpoint in non-Hodgkin's lymphomas.
van 't Veer MB
Neth J Med; 1990 Aug; 37(1-2):37-43. PubMed ID: 2215832
[TBL] [Abstract][Full Text] [Related]
18. Role of polymorphic loci in HLA-region rs2647012 and rs805288 in the development of non-Hodgkin's malignant lymphomas in Western Siberia.
Weiner AS; Berezina OV; Ovchinnikov VS; Surovtseva MN; Voropaeva EN; Pospelova TI; Filipenko ML
Bull Exp Biol Med; 2014 Jun; 157(2):180-3. PubMed ID: 24958370
[TBL] [Abstract][Full Text] [Related]
19. Metabolic gene variants and risk of non-Hodgkin's lymphoma.
De Roos AJ; Gold LS; Wang S; Hartge P; Cerhan JR; Cozen W; Yeager M; Chanock S; Rothman N; Severson RK
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1647-53. PubMed ID: 16985026
[TBL] [Abstract][Full Text] [Related]
20. Role of genetic factors in development and progression of non-Hodgkin's lymphomas.
Soucek P
Cent Eur J Public Health; 2001 May; 9(2):74-8. PubMed ID: 11503278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
